ACD is a typical T-cell-mediated disorder, and the CD8+ effector T lymphocytes are likely the predominant effector population in ACD, especially the CD8+ T cytotoxic type I (Tc1) cells3,4. Here, CD8A is linked to granular corneal dystrophy type II.